Clinical Trials Sponsored by Courage Kenny Rehabilitation Institute
Total 1 results
-
AbiliTech Medical Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
Sponsors and Collaborators
- Only For Children Pharmaceuticals
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Kuwait University
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Sahar Salehi
- Hopeful Aging
- Kerstyn C. Zalesin, M.D.
- Klinikum Bad Woerishofen
- Marcus Vinícius Guimarães de Lacerda
- Hoersholm Hospital
- Pancreatic Cancer UK
- Egyptian Russian University
- Van Boven, Robert W., M.D.
- Genuv Inc.
- The People's Hospital of Guangxi Zhang Autonomous Region
- Liming Cheng
- Jia Liu
- Royal Hobart Hospital Research Foundation (funding source)
- Xiao-Ming Mao
- View Full List
Medical Conditions
- Caffeine Dosage
- Airway Obstruction
- Enlarged Uterus
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- EHMT1
- Stage II Vulvar Cancer
- Smith-Lemli-Opitz Syndrome
- Gait Variability; Elders; Fall; Re-education
- Raynaud Secondary to Other Autoimmune Disease
- Urinary Tract Carcinoma
- Stereotype-threat
- Pulmonary Invasive Aspergillosis
- Pancytopenia Due to Chemotherapy
- High Perinatal Mortality
- Global Health
- Secondary Hypertension to Endocrine Disorders
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Role of Vitamin D in IVF for Better Outcome
- Advanced Gastric Cancer With Serosal Invasion
- Autologous Haematopoietic Stem Cell Transplant
- View Full List
Drug Interventions
- Mupirocin Calcium
- Epimedium Prenylflavonoids Extract
- Bortezomib/dexamethasone
- Polyethylene glycol 3350
- Flibanserin 100 mg dose every evening
- Enzalutamide, Abiraterone
- Cetrorelix 78 mg + 78 mg
- Methotrexate
- PF-00868554
- Lamivudine
- Cytarabine ARA-C
- Atezolizumab
- Ruxolitinib
- Indoximod
- Insulin
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Oxycodone, fentanyl
- Topotecan
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- SERETIDE Diskus
- View Full List
CROs by country
- Contract Research Organizations in Colombia
- Contract Research Organizations in Croatia
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Iran
- Contract Research Organizations in Malawi
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Norway
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Slovenia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Sweden
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Venezuela
- CRO list by country